IRSB - Iris BioTechnologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.11M
Enterprise Value 31.07M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1,867.46
Price/Book (mrq)N/A
Enterprise Value/Revenue 31,792.88
Enterprise Value/EBITDA 6-1.12

Trading Information

Stock Price History

Beta (3Y Monthly) -0.89
52-Week Change 3-74.93%
S&P500 52-Week Change 36.70%
52 Week High 30.4100
52 Week Low 30.0351
50-Day Moving Average 30.0400
200-Day Moving Average 30.0481

Share Statistics

Avg Vol (3 month) 31.08k
Avg Vol (10 day) 3714
Shares Outstanding 5N/A
Float 8.02M
% Held by Insiders 170.70%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2015
Most Recent Quarter (mrq)Sep 30, 2016

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-160,728.23%

Management Effectiveness

Return on Assets (ttm)-938.89%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)595
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -949.09k
Net Income Avi to Common (ttm)-1.36M
Diluted EPS (ttm)-0.0710
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.95k
Total Cash Per Share (mrq)0
Total Debt (mrq)326.7k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.02
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-267.63k
Levered Free Cash Flow (ttm)102.68k